Who founded Invitris?

Invitris was founded by Patrick Grossmann, Kilian Vogele in 2022.

Who are Invitris's investors?

Invitris's investors include Markovian, Y Combinator, 10x Founders, another.vc, Capitalize VC, Phoenix Fund, Ricon GmbH.

Where is Invitris headquartered?

Invitris is headquartered in Munich, DE.

Invitris

YC W23

Munich, DE · Founded 2022 · 6 employees · 7 known investors

Find your way into Invitris

Paths you didn't know you had: your email and LinkedIn already hold routes to the Invitris team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

Biotech Deep Tech Healthtech Nanotechnology Drug discoveryGermanyEuropePartly Remote

Founders & leadership· Y Combinator alumni (W23)

Invitris was founded in 2022 by Patrick Grossmann and Kilian Vogele.

Patrick Grossmann CEO & Co-FounderPatrick Grossmann studied bioinformatics at Harvard Medical School and ETH Zurich, and holds a PhD and MBA. He co-founded Invitris to develop tools for accelerating drug development focused on combating antibiotic resistance.

Kilian Vogele CTO & Co-FounderHe holds a PhD in synthetic biology from TUM and has authored five patents.

Investors · 7

Markovianlisted by Markovian$50K

How we know: Markovian's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

10x FoundersreportedMünchen · $270K – $2.7M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

another.vcreportedMülheim an der Ruhr · $108K

How we know: Y Combinator's founder network · Not right? Tell us

Capitalize VCreportedChicago · $100K – $200K

How we know: Y Combinator's founder network · Not right? Tell us

Phoenix FundreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Ricon GmbHreported

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 6

Helix NanotechnologiesHelix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.

AmyrisAmyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.

AryllaArylla produces invisible ink tags using nanotechnology that can be applied to fashion products and read via smartphone to enable authentication, traceability, and personalized customer experiences. The tags integrate with third-party platforms like WeChat and WhatsApp to connect consumers with branded content and product verification.

Nomic BioNomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

spotLESS MaterialsspotLESS Materials develops nature-inspired liquid-entrenched smooth surface (LESS) coatings that repel liquids, sludge, and contaminants while enabling self-cleaning properties for industrial applications including sanitation, automotive, and medical sectors.

Kern SystemsKern Systems develops a cold data storage platform using synthetic DNA molecules and enzymes to archive data with superior density, durability, and energy efficiency compared to traditional storage technologies. The platform targets the growing market for long-term archival storage of rarely-accessed unstructured data.

Companies working in the same space as Invitris.

Legal entities · 1

corporate structure

Invitris Inc.

In the news

INVITRIS - Simplifying drug development & manufacturingycombinator.com · Mar 2023

Frequently asked questions

What does Invitris do?: Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
Who founded Invitris?: Invitris was founded by Patrick Grossmann, Kilian Vogele in 2022.
Who are Invitris's investors?: Invitris's investors include Markovian, Y Combinator, 10x Founders, another.vc, Capitalize VC, Phoenix Fund, Ricon GmbH.
Where is Invitris headquartered?: Invitris is headquartered in Munich, DE.